Blood Testing Market to Reach USD 144.80 Billion by 2031, Driven by Rising Chronic Disease Prevalence and Home Care Demand

Mordor Intelligence has published a new report on the Global blood testing market offering a comprehensive analysis of trends, growth drivers, and future projections.

Introduction: Blood Testing Market Forecast & Outlook

The global blood testing market is poised for robust growth over the coming years. According to the latest Mordor Intelligence report, the market is estimated at USD 103.53 billion in 2026, and is projected to reach USD 144.80 billion by 2031. This represents a compound annual growth trajectory of about 6.94 percent through the forecast period.

In this time frame, the blood testing market size will expand due to growing demand for early disease detection, the push for home-based diagnostics, and increasing research investments. The expansion will vary across geographies, with North America remaining a major contributor and Asia-Pacific emerging as the fastest growing region.

Report Overview: https://www.mordorintelligence.com/industry-reports/blood-testing-market?utm_source=openpr

Key Trends Shaping the Blood Testing Market

Rising Incidence of Chronic Diseases

One of the primary forces behind growth in the blood testing market is the increasing burden of chronic illnesses such as diabetes, cardiovascular diseases, and cancer. Because blood biomarkers play a central role in detecting, monitoring, and managing these diseases, demand for blood testing is rising steadily.

Growth of Home Healthcare & Self-Testing

Patients and caregivers are showing greater preference for tests that can be done at home or point-of-care. For instance, glucose testing at home is already common and continues to expand. This trend contributes to the blood testing market growth, allowing testing outside traditional clinical settings.

Innovation in Diagnostic Technologies

Developments in diagnostic technologies-such as miniaturization, automation, and improved sensitivity-are enabling more efficient and accurate blood tests. New test types that detect earlier disease signals or rare biomarkers are entering the market, advancing overall capability.

Geographic Shift & Emerging Regions

While North America is expected to maintain the largest individual share of the blood testing market, the Asia-Pacific region is projected to record the fastest growth rate over the forecast period. Factors such as increasing healthcare access, growing middle classes, and rising disease burden in Asia are driving this momentum.

Regulatory Hurdles as a Challenge

A consistent complicating factor for market players is the stringent regulatory approval processes that apply to blood diagnostics. Such regulations may slow product launches and market entry, which could constrain faster growth despite favorable demand.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/blood-testing-market?utm_source=openpr

Market Segmentation in the Blood Testing Market

The blood testing market is segmented across multiple dimensions: type of test, method, end user, and geography. Below is a breakdown of these segments along with some highlights of their contributions to market structure.

By Type

The tests in this segment include:

Glucose testing (measuring blood sugar levels)

Lipid panel testing

Prostate-specific antigen (PSA) testing

Blood urea nitrogen (BUN) testing

Thyroid stimulating hormone (TSH) testing

Other types (e.g., direct LDL, testosterone)

Notably, the glucose testing segment captures a significant share due to the high prevalence of diabetes and the routine nature of glucose monitoring.

By Method

Manual blood testing

Automated blood testing

Automated blood testing systems are attracting attention because they offer greater throughput, consistency, and lower margin for human error-features favored in large diagnostic settings.

By End User

Diagnostic laboratories

Hospitals

Other end users (clinics, research centers, specialized centers)

Diagnostic laboratories remain crucial in the value chain, especially for high volume and specialized tests. Hospitals also account for substantial share, especially for in-patient or complex testing needs.

By Geography

Regionally, the market is divided into:

North America (United States, Canada, Mexico)

Europe (Germany, United Kingdom, France, Italy, Spain, rest of Europe)

Asia-Pacific (China, Japan, India, Australia, South Korea, rest)

Middle East & Africa (GCC, South Africa, rest)

South America (Brazil, Argentina, rest)

Each region shows different demand profiles: North America leads in market share, and Asia-Pacific is expected to grow at the fastest rate.

Thus, stakeholders should analyze not just the global blood testing market size, but the specific growth in each segment to understand where opportunities lie.

Explore blood testing market Research Industry Reports - https://www.mordorintelligence.com/industry-reports/blood-testing-market?utm_source=openpr

Key Players in the Blood Testing Market

The blood testing market share is distributed among a number of global diagnostic and life science firms. Some of the key players mentioned in the Mordor Intelligence report are:

Danaher Corporation

BioRad Laboratories

Abbott Laboratories

BioMérieux SA

Thermo Fisher Scientific

These firms engage in strategic moves-such as product launches, partnerships, mergers, acquisitions, and geographic expansion-to strengthen their position in the blood testing market.

For example, some players are actively launching at-home blood tests or kits that simplify sample collection and shipping. Their competitive strategies help define relative market share, as well as influence which product types and regions gain traction.

Because the blood testing market is moderately fragmented, there remains room for mid-size players and niche innovators to capture share through specialization or regional focus.

Explore more insights on blood testing market competitive landscape: https://www.mordorintelligence.com/industry-reports/blood-testing-market/companies?utm_source=openpr


Conclusion & Outlook for Blood Testing Market

The blood testing market is entering a period of sustained expansion, driven by increasing demand for diagnostics, especially chronic conditions, coupled with advancements in test methods and deployment settings.

However, the pace of growth depends on how well companies navigate regulatory environments, bring test innovations to market, and respond to regional healthcare infrastructure differences. The segmentation of testing types, methods, and end users provides varied paths for expansion.

Industry related Reports:

Patient Monitoring Devices Market: The Patient Monitoring Devices Market Report Segments the Industry Into by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Multi-Parameter Monitors, and More), by Application (Cardiology, Neurology, Respiratory, and More), by End-User (Home Healthcare, Hospitals and Clinics, and More), and Geography (North America, and More).

Get more Insights: https://www.mordorintelligence.com/industry-reports/patient-monitoring-devices-market?utm_source=openpr

Companion Diagnostics Market: he Companion Diagnostics Market Report Segments the Industry Into Technology (Immunohistochemistry, Polymerase Chain Reaction, and More), Indication (Lung Cancer, Breast Cancer, and More), Product Type (Assays and Kits, and Instruments and Analyzers, and More), Sample Type (Tissue Biopsy, Liquid Biopsy, and More), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and More), and Geography.

Get more Insights: https://www.mordorintelligence.com/industry-reports/companion-diagnostics-market?utm_source=openpr

Genetic Testing Market: The Genetic Testing Market Report is Segmented by Product & Service (Consumables and Reagents, Equipment and Instruments, Software and Services), Test Type (Diagnostic, Prenatal & Newborn, and More), Technology (NGS, and More), Application (Oncology, Genetic Disease Diagnosis, and More), End User (Hospitals & Clinics, and More), and Geography (North America, and More).

Get more Insights: https://www.mordorintelligence.com/industry-reports/global-genetic-testing-market-industry?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.